Brief: Nurix Therapeutics Inc - Entered Into A Multi-Year, Multi-Target Strategic Collaboration Agreement With Seagen Inc

Nurix Therapeutics

07/09/2023 12:52

Sept 7 (Reuters) - Nurix Therapeutics Inc  NRIX.O :
    * NURIX THERAPEUTICS INC - ENTERED INTO A MULTI-YEAR,
MULTI-TARGET
STRATEGIC COLLABORATION AGREEMENT WITH SEAGEN INC
    * NURIX THERAPEUTICS - TO RECEIVE $60 MILLION UPFRONT
PAYMENT, IN
ADDITION TO POTENTIAL FOR ABOUT $3.4 BILLION IN MILESTONE
PAYMENTS PLUS FUTURE ROYALTIES
    * NURIX THERAPEUTICS INC - RETAINS AN OPTION FOR U.S. PROFIT
SHARING AND CO-PROMOTION ON TWO PRODUCTS ARISING FROM
COLLABORATION
    * NURIX THERAPEUTICS INC - SEVERAL DAC DRUGS MAY BE
DEVELOPED AND
COMMERCIALIZED WITHIN THIS COLLABORATION
    * NURIX THERAPEUTICS - EXPECTS EXISTING CASH, CASH
EQUIVALENTS AND
MARKETABLE SECURITIES, WILL BE SUFFICIENT TO FUND OPERATING
ACTIVITIES INTO Q2 2025

Source text for Eikon:  ID:nGNX7v7FqQ 
Further company coverage:  NRIX.O 

 (Reporting by ArsheeyaSingh Bajwa)
 ((ArsheeyaSingh.Bajwa@thomsonreuters.com;))